Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
0.440
-0.031 (-6.56%)
At close: Jul 19, 2024, 4:00 PM
0.408
-0.032 (-7.29%)
Pre-market: Jul 22, 2024, 7:41 AM EDT
Aptevo Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aptevo Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for APVO.
Recommendation Trends
Rating | Dec '21 | Jan '22 | Feb '22 | Mar '22 | Apr '22 | May '22 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $3,036 → $880 | Buy | Maintains | $3,036 → $880 | +199,854.56% | May 13, 2022 |
Roth Capital | Roth Capital | Strong Buy Maintains $2,816 → $2,200 | Strong Buy | Maintains | $2,816 → $2,200 | +499,786.39% | May 28, 2021 |
Piper Sandler | Piper Sandler | Buy Maintains $1,408 → $3,036 | Buy | Maintains | $1,408 → $3,036 | +689,743.22% | Nov 11, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $7,392 | Strong Buy | Initiates | $7,392 | +1,679,518.27% | Apr 11, 2018 |
Piper Sandler | Piper Sandler | Buy Initiates $4,312 | Buy | Initiates | $4,312 | +979,677.32% | Sep 9, 2016 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-20.58
from -62.48
EPS Next Year
-8.30
from -20.58
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 13.9M | 60.8M | 81.0M |
Avg | n/a | n/a | 6.7M | 59.1M | 78.7M |
Low | n/a | n/a | n/a | 56.8M | 75.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 802.5% | 37.1% |
Avg | - | - | - | 776.7% | 33.1% |
Low | - | - | - | 742.3% | 27.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -9.30 | -6.06 | -3.42 | 1.99 | 3.38 |
Avg | -20.58 | -8.30 | -5.23 | 1.94 | 3.28 |
Low | -30.87 | -10.29 | -6.86 | 1.86 | 3.16 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 74.5% |
Avg | - | - | - | - | 69.5% |
Low | - | - | - | - | 62.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.